Clinical Outcome and Drug Expenses of Intravitreal Therapy for Diabetic Macular Edema: A Retrospective Study in Sardinia, Italy

Clinical Outcome and Drug Expenses of Intravitreal Therapy for Diabetic Macular Edema: A Retrospective Study in Sardinia, Italy

Background: Diabetic macular edema (DME) is a leading cause of visual loss in working-age adults. The purpose of this retrospective study was to perform an epidemiological analysis on DME patients treated with intravitreal drugs in a tertiary hospital. The clinical outcome, adverse drug reactions (A...

Full description

Bibliographic Details
Main Authors:	Chiara Altana, Matthew Gavino Donadu, Stefano Dore, Giacomo Boscia, Gabriella Carmelita, Stefania Zanetti, Francesco Boscia, Antonio Pinna
Format:	Article
Language:	English
Published:	MDPI AG 2021-11-01
Series:	Journal of Clinical Medicine
Subjects:	diabetic macular edema intravitreal agents best corrected visual acuity central retinal thickness adverse drug reactions intravitreal drug expenses
Online Access:	https://www.mdpi.com/2077-0383/10/22/5342

Similar Items

Intravitreal Diclofenac for Refractory Uveitic Cystoid Macular Edema
by: Alireza Ramezani, et al.
Published: (2013-01-01)

Non-steroidal anti-inflammatory drug in adjuvant treatment of intravitreal triamcinolone acetonide for macular edema
by: Xiao-Juan Liu, et al.
Published: (2016-06-01)

Intravitreal Ranibizumab for Diabetic Macular Edema Patients with Good Baseline Visual Acuity: A Real-Life Study
by: Abdullah Ozkaya, et al.
Published: (2017-10-01)

Comparison of intravitreal bevacizumab, intravitreal triamcinolone acetonide, and macular grid augmentation in refractory diffuse diabetic macular edema: A prospective, randomized study
by: Rajvardhan Azad, et al.
Published: (2012-01-01)

Intravitreal Injections of 4 mg and 20 mg Triamcinolone Acetonide in the Treatment of Diabetic Macular Edema: Comparison of Efficacy and Side Effects
by: Erkan Ünsal, et al.
Published: (2015-01-01)

Real-World Evidence of the Long-Term Effectiveness of 0.2 μg/Day Fluocinolone Acetonide Implant in Persistent and Recurrent Diabetic Macular Edema – A Single Center Study
by: Soares RM, et al.
Published: (2024-04-01)

Real-world outcomes of two-year Conbercept therapy for diabetic macular edema
by: Yong Cheng, et al.
Published: (2021-03-01)

Recurrent Diabetic Macular Edema: What to Do
by: Rita Santos Gonçalves, et al.
Published: (2017-09-01)

The effects of intravitreal adalimumab injection on pseudophakic macular edema
by: Mohsen Farvardin, et al.
Published: (2020-07-01)

Effects of Intra-Vitreal Diclofenac in Refractory Diabetic Macular Edema
by: Syed Hassan Massana, et al.
Published: (2022-12-01)

Intravitreal bevacizumab injections for diabetic macular edema – predictors of response: a retrospective study
by: Joshi L, et al.
Published: (2016-10-01)

Outcomes of Intravitreal Triamcinolone Acetonide Injection in Patients With Diabetic Macular Edema
by: Lokman Balyen, et al.
Published: (2018-01-01)

Efficacy of intravitreal Conbercept injection for macular edema secondary to macular branch retinal vein occlusion
by: Ping-Li Zhu, et al.
Published: (2018-01-01)

COMPARISON OF INTRAVITREAL BEVACIZUMAB AND TRIAMCINOLONE ACETONIDE WITH INTRAVITREAL BEVACIZUMAB ALONE IN MACULAR EDEMA SECONDARY TO CENTRAL RETINAL VEIN OCCLUSION
by: Usman Attique, et al.
Published: (2021-03-01)

Short-term effect of intravitreal dexamethasone implant in refractory diabetic macular edema
by: Jazmín Baca Moreno, et al.
Published: (2024-03-01)

Effects of retrobulbar or intravitreal injection of triamcinolone acetonide combined with laser photocoagulation for diabetic macular edema
by: Ling Deng, et al.
Published: (2018-08-01)

Intravitreal Dexamethasone Implants for Refractory Macular Edema in Eyes with Noninfectious Uveitis
by: Eugene Yu-Chuan Kang, et al.
Published: (2021-08-01)

Evaluation of the Effect of Intravitreal Dexamethasone (Ozurdex®) Implant on Intraocular Pressure in Vitrectomized and Non-Vitrectomized Eyes with Macular Edema
by: Murat Garlı, et al.
Published: (2021-12-01)

Characteristics of macular edema in behcet disease after intravitreal bevacizumab injection
by: Fariba Ghassemi, et al.
Published: (2017-01-01)

Dexamethasone intravitreal implant in cystoid macular edema secondary to paclitaxel therapy
by: Barbara Burgos-Blasco, et al.
Published: (2020-06-01)

Bilateral Intravitreal Dexamethasone Implant for Retinitis Pigmentosa-Related Macular Edema
by: Ali Osman Saatci, et al.
Published: (2013-03-01)

Safety and efficacy profile of intravitreal ranibizumab vs dexamethasone in treatment of naïve diabetic macular edema
by: Santosh K Mahapatra, et al.
Published: (2024-01-01)

Evaluation of intravitreal corticosteroids as an adjuvant to bevacizumab for diabetic macular edema using electroretinogram
by: Hesham A Enany
Published: (2015-01-01)

Intravitreal lucentis combined laser photocoagulation treatment on macular edema
by: Tan-Wei Wei, et al.
Published: (2013-05-01)

Efficacy of intravitreal injection of Conbercept in the treatment of diabetic macular edema
by: Chen Jiang, et al.
Published: (2018-02-01)

Intravitreal Dexamethasone Implant for the Treatment of Patient with Resistant to Anti-VEGF Diabetic Macular Edema
by: M. M. Bikbov, et al.
Published: (2020-08-01)

Dexamethasone intravitreal implant in the treatment of diabetic macular edema
by: Ke-Ke Hu, et al.
Published: (2022-12-01)

Suprachoroidal versus Intravitreal Triamcinolone Acetonide for the Treatment of Diabetic Macular Edema
by: Zakaria YG, et al.
Published: (2022-03-01)

Intravitreal injection of conbercept combined with triamcinolone acetonide for diabetic macular edema
by: Jun Li<sup>*</sup>, et al.
Published: (2019-03-01)

Efficacy and safety of sustained-delivery fluocinolone acetonide intravitreal implant in patients with chronic diabetic macular edema insufficiently responsive to available therapies: a real-life study
by: Massin P, et al.
Published: (2016-07-01)

Clinical observation on the efficacy of refractory macular edema secondary to non-infectious uveitis of Dexamethasone intravitreal implant
by: Ji-Zi Jiang, et al.
Published: (2022-11-01)

Clinical Application of Intravitreal Aflibercept Injection for Diabetic Macular Edema Comparing Two Loading Regimens
by: Yoo-Ri Chung, et al.
Published: (2023-03-01)

Title: efficacy of intravitreal dexamethasone implant on hard exudate in diabetic macular edema
by: Chang Ki Yoon, et al.
Published: (2021-01-01)

Treatment of Diabetic Macular Edema or Macular Edema Following Retinal Vein Occlusion Based on Repeated Injection of the Dexamethasone Intravitreal Implant: A Retrospective Real-World Analysis
by: Sanders FW, et al.
Published: (2023-10-01)

Pseudophakic macular edema in nondiabetic and diabetic patients without diabetic retinopathy treated with intravitreal dexamethasone implant
by: Magna Vanessa Rodrigues, et al.
Published: (2023-09-01)

Intravitreal Aflibercept versus Laser Photocoagulation in Asian Patients with Diabetic Macular Edema: The VIVID-East Study
by: Chen YX, et al.
Published: (2020-03-01)

Short-term outcomes after the loading phase of intravitreal bevacizumab and subthreshold macular laser in non-center involved diabetic macular edema
by: Edgar Cuervo-Lozano, et al.
Published: (2018-06-01)

Comparative characteristics of the outcomes of the use of multidirectional intravitreal pharmacotherapy in the treatment of diabetic macular edema
by: M. M. Bikbov, et al.
Published: (2021-04-01)

Effect of Intravitreal Triamcinolone on Different Optical Coherence Tomographic Patterns of Diabetic Macular Edema
by: Arif Koytak, et al.
Published: (2014-01-01)

Evaluation of diabetic macular edema by using optical coherence tomography in patients underwent combined phacoemulsification and intravitreal ranibizumab injection versus patients underwent sequential intravitreal ranibizumab injection and phacoemulsification: an observational study
by: Mohamed T El-Behaidy, et al.
Published: (2023-01-01)